New lab device records cancer cells metastasizing on the microscopic level
the ONA take:
Current imaging technology can only provide a limited view of how cancer cells migrate to blood vessels and spread through the body. Improved imaging would give clinicians better insight into the metastasis process, which causes a majority of cancer-related mortality. The bloodstream provides a fast means of transport for cancer cells wishing to spread throughout the body.
Engineers based at Johns Hopkins’ Whiting School of Engineering and its Institute for NanoBioTechnology (INBT) developed a lab chip system that allows them to record the movement of cancer cells on the microscopic level. Early stages of metastasis were recreated on this chip, which includes an artificial blood vessel replicated via a three-dimensional collagen matrix. The material employed behaves similarly to healthy human tissue that surrounds tumors and is often the target of cancer metastases.
Investigators were able to record video of breast cancer cells moving through the matrix. Lead researcher, Andrew D. Wong, reported that his team was also able to obtain video footage of individual cancer cells pushing through the wall of an artificial blood vessel, a process that matches early metastasis.
This new artificial blood vessel and micro environment provides an ideal way to observe the minute details of metastasis, and can help shed insight into ways to stop or slow steps in the metastatic cascade.
A lab chip system allows you to record the movement of cancer cells on the microscopic level.
Johns Hopkins engineers have invented a lab device to give cancer researchers an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90 percent of cancer-related deaths. By shedding light on precisely how tumor cells travel, the device could uncover new ways to keep cancer in check.
The inventors, from the university's Whiting School of Engineering and its Institute for NanoBioTechnology (INBT), published details and images from their new system recently in the journal Cancer Research.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|